Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido [1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-a] pyrimidin-5(1H)one derivatives for neurodegenerative disorders

Details for Australian Patent Application No. 2002342798 (hide)

International Classifications

Event Publications

27 February 2003 Complete Application Filed

Priority application(s): 01402431.9 21.09.01 EP; 02290488.2 28.02.02 EP

26 June 2003 Application Open to Public Inspection

Published as AU-B-2002342798

24 February 2005 Change of Name(s) of Applicant(s), Section 104

Sanofi-Synthelabo The name of the applicant has been changed to Mitsubishi Pharma Corporation; Sanofi-Aventis Change of Name(s) of Applicant(s), Section 104

10 January 2008 Application Accepted

Published as AU-B-2002342798

8 May 2008 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 15 Apr 2008. Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000 2003

8 May 2008 Standard Patent Sealed

25 September 2008 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 15 Apr 2008 2003

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.